Zhejiang Taimei Medical Technology Shareholders Approve All Resolutions at 2026 Extraordinary Meeting

Zhejiang Taimei Medical Technology Co Ltd Class H ( (HK:2576) ) has provided an announcement.

Zhejiang Taimei Medical Technology Co., Ltd. announced that all resolutions proposed at its first extraordinary general meeting of 2026 were approved by shareholders through a poll. The meeting, held in Shanghai and chaired by executive director and board chairman Mr. Zhao, saw participation from holders of about 65% of the company’s issued shares, excluding treasury stock.

Core connected persons, including Mr. Zhao and his associates, abstained from voting on resolutions related to conditional award grants to several executives, in line with governance requirements on conflicts of interest. All directors attended the meeting either in person or electronically, and Computershare Hong Kong Investor Services Limited acted as scrutineer, underscoring procedural compliance and transparency in the company’s decision-making process.

The most recent analyst rating on (HK:2576) stock is a Hold with a HK$5.00 price target. To see the full list of analyst forecasts on Zhejiang Taimei Medical Technology Co Ltd Class H stock, see the HK:2576 Stock Forecast page.

More about Zhejiang Taimei Medical Technology Co Ltd Class H

Zhejiang Taimei Medical Technology Co., Ltd. is a mainland China-based company listed in Hong Kong as a joint stock company with limited liability. It operates in the medical technology sector and has both H shares and domestic shares, reflecting a focus on serving investors in Hong Kong and the domestic Chinese market.

Average Trading Volume: 56,668

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$2.75B

For an in-depth examination of 2576 stock, go to TipRanks’ Overview page.